MSP3-CRM-Vac4All/ Alhydrogel® Vaccine

Clinical trial NCT05776017 · UNKNOWN

Trial details

NCT number: NCT05776017
Sponsor: Vac4All
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malaria,Falciparum

Start date: 2023-03-27
Primary completion: 2023-12-31
Enrollment: 465

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.